Today: 7 February 2026
Subscribe

Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

Nvidia stock price ticks up premarket as CoreWeave stake, Fed week put NVDA back in focus

Nvidia stock price ticks up premarket as CoreWeave stake, Fed week put NVDA back in focus

Nvidia shares rose 0.4% in premarket trading Tuesday, reaching $187.23 after closing at $186.47. Nvidia invested $2 billion in CoreWeave, nearly doubling its stake. Samsung will begin HBM4 chip production next month, aiming to supply Nvidia. Investors await the Federal Reserve decision Wednesday and Nvidia’s earnings on Feb. 25.
27 January 2026
·····
Broadcom stock price rises as Wall Street sets up for Fed call and big-tech earnings (AVGO)

Broadcom stock price rises as Wall Street sets up for Fed call and big-tech earnings (AVGO)

Broadcom shares rose 1.5% to $324.85 in early Tuesday trading, leading chip stocks higher after Micron’s $24 billion Singapore plant announcement. Investors shifted into top tech names ahead of the Federal Reserve’s rate decision and a wave of mega-cap earnings. Focus remains on whether AI spending will lift profits amid margin concerns.
27 January 2026
·····
SLB stock price edges higher near a fresh high as banks lift targets again

SLB stock price edges higher near a fresh high as banks lift targets again

SLB shares closed Monday up 1.1% at $49.70, trailing Baker Hughes’ 4.4% gain. JPMorgan and RBC raised their SLB price targets to $54 after the company’s 2026 outlook. Trading volume in SLB was well above average. U.S. officials are reportedly in talks with Chevron and oil-service firms, including SLB, about boosting Venezuelan crude output.
27 January 2026
·····
Bloom Energy stock drops as Jefferies lifts target but stays bearish ahead of Feb. 5 results

Bloom Energy stock drops as Jefferies lifts target but stays bearish ahead of Feb. 5 results

Bloom Energy shares fell 3.7% to $139.62 Monday, underperforming the S&P 500’s 0.5% gain. Jefferies raised its price target to $92 but kept an Underperform rating, warning expectations are high. Investors await Bloom’s Feb. 5 results for updates on 2026 deployments and margins. Other fuel-cell stocks, including Plug Power and FuelCell Energy, also dropped.
27 January 2026
·········
RTX stock slips ahead of earnings as Airbus flags Pratt & Whitney engine bottlenecks

RTX stock slips ahead of earnings as Airbus flags Pratt & Whitney engine bottlenecks

RTX shares fell 0.9% to $194.13 Monday ahead of its earnings report due before Tuesday’s open. Airbus flagged ongoing delivery problems with Pratt & Whitney engines, raising pressure on RTX. Options trading suggests a 5% stock move after results. Wall Street expects earnings of $1.47 per share on $22.7 billion in revenue.
27 January 2026
·····
Intuitive Surgical stock in focus after FDA clears da Vinci 5 for heart procedures

Intuitive Surgical stock in focus after FDA clears da Vinci 5 for heart procedures

Intuitive Surgical shares rose nearly 1% to $528.81 after U.S. regulators cleared its da Vinci 5 system for select cardiac procedures. The FDA approval covers thoracoscopic cardiac surgeries using non-force feedback tools. TD Cowen started coverage with a Buy rating and a $660 price target. About 17,000 da Vinci cardiac procedures were performed globally in 2025.
27 January 2026
···
Nebius (NBIS) stock drops 3% after wild swing as traders look to the next catalyst

Nebius (NBIS) stock drops 3% after wild swing as traders look to the next catalyst

Nebius Group shares fell 3.2% to $91.46 Monday, underperforming the S&P 500 and tech peers despite heavy trading and a session swing from $100.82 to $91.35. The company faces scrutiny over cash needs and expansion plans as it prepares to deploy Nvidia’s new “Rubin” platform and chases multi-billion-dollar AI infrastructure deals with Microsoft and Meta.
27 January 2026
····
Citigroup stock edges higher as harassment lawsuit hits headlines ahead of Fed meeting

Citigroup stock edges higher as harassment lawsuit hits headlines ahead of Fed meeting

Citigroup shares closed up 0.9% at $114.65 Monday, edging higher after hours despite news of a lawsuit alleging mishandled sexual harassment claims by a former managing director. The suit names Andy Sieg, head of Citi’s wealth division; Citi called the allegations “absolutely meritless.” The stock’s move tracked gains in other major banks ahead of a key Federal Reserve meeting starting Tuesday.
27 January 2026
···
Starbucks stock price slips after hours as Wall Street lines up earnings and investor day (SBUX)

Starbucks stock price slips after hours as Wall Street lines up earnings and investor day (SBUX)

Starbucks shares fell 1.3% after hours Monday to $96.33. Analysts expect Q1 revenue of $9.63 billion and earnings per share of $0.57, with U.S. same-store sales seen rising 3% to 4%. The company reports earnings Jan. 28 and holds an investor day Jan. 29. A proxy filing set the annual meeting for March 25.
27 January 2026
····
Uber stock slips as NYC forces 10% tip prompt on Uber Eats orders; focus turns to Feb. 4 earnings

Uber stock slips as NYC forces 10% tip prompt on Uber Eats orders; focus turns to Feb. 4 earnings

Uber shares fell 0.4% to $81.98 Monday after New York City’s new tipping rules for delivery apps took effect. DoorDash, Uber, and Instacart failed to block the regulations in court and plan to appeal. The rules require a tip prompt at checkout and ban hidden or delayed tipping options. Investors await Uber’s Feb. 4 earnings for signs of regulatory impact on delivery demand and costs.
27 January 2026
····
Boston Scientific (BSX) stock ticks higher again — what to watch before Tuesday’s trade

Boston Scientific (BSX) stock ticks higher again — what to watch before Tuesday’s trade

Boston Scientific shares rose 1.12% to $93.55 Monday, outperforming Medtronic but lagging Abbott and Stryker. The company faces FDA scrutiny over its AXIOS GI stent after reports of injuries and deaths. Investors are focused on the $14.5 billion Penumbra acquisition, expected to close in 2026. Quarterly results are due Feb. 4.
27 January 2026
·····
Gilead (GILD) stock hits fresh 52-week high as new analyst targets and CEO sale filing land

Gilead (GILD) stock hits fresh 52-week high as new analyst targets and CEO sale filing land

Gilead Sciences shares closed at a 52-week high of $137.78 on Monday, up 1.36% for a fourth straight gain. CEO Daniel O’Day sold $15.6 million in stock under a pre-set plan, according to an SEC filing. BMO and UBS raised their price targets, citing momentum in HIV drugs and new coverage for Yeztugo. Trading volume exceeded normal levels as the stock outperformed major pharma peers.
27 January 2026
····
1 … 165 166 167 168 169 … 1,008

Stock Market Today

RELX share price slides again as AI fears linger, results next week in focus

RELX share price slides again as AI fears linger, results next week in focus

7 February 2026
RELX closed down 4.6% at 2,145 pence in London on Friday, capping a volatile week ahead of its Feb. 12 full-year results. The company bought back 465,361 shares even as selling continued amid investor concerns over AI risks and pricing power. Peers Wolters Kluwer and Thomson Reuters also faced pressure. Markets await RELX’s outlook for 2026 trading.
Rio Tinto stock jumps as Glencore mega-merger is shelved; what to watch next week

Rio Tinto stock jumps as Glencore mega-merger is shelved; what to watch next week

7 February 2026
Rio Tinto’s U.S. shares closed up 2.5% at $93.37 Friday after the company ruled out a merger with Glencore, triggering a six-month “no-bid” lockout under UK takeover rules. Both companies cited disagreements over valuation. Attention now turns to Rio’s Feb. 19 results and iron ore prices, which fell below $100 a tonne amid weak Chinese demand.
Go toTop